Talquetamab for treating relapsed or refractory multiple myeloma after 3 treatments [ID5082]

  • In development
  • GID-TA10969
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 5082